Yu Hou

1.5k total citations · 2 hit papers
55 papers, 1.0k citations indexed

About

Yu Hou is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Yu Hou has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Hematology. Recurrent topics in Yu Hou's work include Acute Myeloid Leukemia Research (10 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yu Hou is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yu Hou collaborates with scholars based in China, United States and United Kingdom. Yu Hou's co-authors include Zhe Chen, Jieping Chen, C. C. Huang, Hanhua Cheng, Rongjia Zhou, Guanbin Song, Weiru Wu, Chunli Gong, Yang Chen and Yongxiu Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Yu Hou

51 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification

2022 154 citations Yu Hou et al. profile →
Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening

2024 49 citations Chengfang Zhou, Tao Yin et al. Cell stem cell profile →

Peers

Countries citing papers authored by Yu Hou

Since Specialization

Citations

This map shows the geographic impact of Yu Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Hou more than expected).

Fields of papers citing papers by Yu Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Hou. The network helps show where Yu Hou may publish in the future.

Co-authorship network of co-authors of Yu Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Hou. A scholar is included among the top collaborators of Yu Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Hou. Yu Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NGR1 reduces neuronal apoptosis through regulation of ITGA11 following subarachnoid hemorrhage 2025 ·Molecular Medicine Reports ·Yu Hou, Lihan Zhang, (unknown), Yong Jiang	0
2	Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import 2025 ·Oncogene ·(unknown), Ruiying Zhao, Yifan Zheng, Yan Li, Feng Wu, (unknown), Lei Li, (unknown), (unknown), Yu Hou	0
3	EMP1 safeguards hematopoietic stem cells by suppressing sphingolipid metabolism and alleviating endoplasmic reticulum stress 2025 ·Nature Communications ·Lei Li, (unknown), Yan Li, Yuxin Xie, (unknown), (unknown), Weiru Wu, Feng Wu, (unknown), Jianming Wang, Jieping Chen, Zhe Chen, Yu Hou	0
4	New insights into extracellular vesicles in metastatic cancer: From mechanisms to diagnostics and targeted therapies 2025 ·Molecular Therapy ·(unknown), Meixi Peng, Yongxiu Huang, Zhengyu Chen, Jian‐Feng Chen, (unknown), Dan Liu, Yu Hou	0
5	A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells 2024 ·Cell Death and Disease ·(unknown), Meixi Peng, (unknown), Zhenyu Wang, (unknown), Yongxiu Huang, (unknown), Yanni Sun, (unknown), Xiaomei Huang, Ting Huang, Li Wang, Jieping Chen, Yu Hou	7
6	Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening breakdown → 2024 ·Cell stem cell ·Chengfang Zhou, (unknown), Tao Yin, Jianming Wang, (unknown), (unknown), (unknown), Zhe Chen, (unknown), Zhigang Li, Weiru Wu, Li Wang, (unknown), Junping Wang, Yu Hou	49
7	Post-transcriptional regulation of DEAD-box RNA helicases in hematopoietic malignancies 2024 ·Genes & Diseases ·(unknown), (unknown), (unknown), Yu Hou	2
8	Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells 2024 ·Leukemia ·Zhigang Li, (unknown), (unknown), Wei Wang, Changlin Zhen, (unknown), Weiru Wu, Yuanyuan Liu, Zhe Chen, (unknown), (unknown), (unknown), Lun Liu, (unknown), (unknown), Yu Hou	23
9	TRIM32 biallelic defects cause limb-girdle muscular dystrophy R8: identification of two novel mutations and investigation of genotype–phenotype correlation 2023 ·Skeletal Muscle ·Yuqing Guan, (unknown), Wei Li, Wanying Lin, (unknown), (unknown), Yu Hou, Yafang Hu, Xuan Shang	4
10	Overcoming adaptive resistance in AML by synergistically targeting FOXO3A-GNG7-mTOR axis with FOXO3A inhibitor Gardenoside and rapamycin 2023 ·Genes & Diseases ·Zhe Chen, Qian Guo, (unknown), Lei Li, Feng Wu, Zhilong Liu, Zhigang Li, Tao Chen, Guanbin Song, Shuangnian Xu, Jieping Chen, Yu Hou	6
11	Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis 2022 ·Bone Marrow Transplantation ·Chengxin Luo, Guixian Wu, (unknown), (unknown), (unknown), (unknown), Yu Hou, Jieping Chen, Xi Li, Shuangnian Xu	2
12	Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis 2021 ·The Journal of Experimental Medicine ·Zhe Chen, Dawei Huo, Lei Li, Zhilong Liu, (unknown), Shuangnian Xu, Yongxiu Huang, Weiru Wu, Chengfang Zhou, (unknown), (unknown), Feng Wu, (unknown), Pengxu Qian, Guanbin Song, Xudong Wu, Jieping Chen, Yu Hou	31
13	Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis 2021 ·Scientific Reports ·Chengxin Luo, Guixian Wu, (unknown), Yanni Ma, Yali Zhang, (unknown), (unknown), Yanni Sun, (unknown), Zhen Huang, Yu Hou, Shuangnian Xu, Jieping Chen, Xi Li	40
14	Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia 2021 ·Leukemia ·Chengfang Zhou, (unknown), Zhilong Liu, (unknown), Zhe Chen, (unknown), Zhigang Li, Weiru Wu, Le Ma, Jieping Chen, Yu Hou	6
15	Long-chain non-coding RNA HOTAIR promotes the progression of osteoarthritis via sponging miR-20b/PTEN axis 2020 ·Life Sciences ·Yingchun Chen, Lin Zhang, (unknown), (unknown), Yu Hou, Wei Yuan, Wei Qu, (unknown)	41
16	A Cdh1–FoxM1–Apc axis controls muscle development and regeneration 2020 ·Cell Death and Disease ·Zhe Chen, Lei Li, Shuangnian Xu, Zhilong Liu, Chengfang Zhou, Zhigang Li, (unknown), Weiru Wu, Yongxiu Huang, (unknown), Shijun Fan, (unknown), Xi Li, Guanbin Song, Wenshu Wu, Jieping Chen, Yu Hou	26
17	DNA Demethylation and USF Regulate the Meiosis-Specific Expression of the Mouse Miwi 2012 ·PLoS Genetics ·Yu Hou, Jia Yuan, Xiang Zhou, Xiazhou Fu, Hanhua Cheng, Rongjia Zhou	32
18	Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation 2011 ·PLoS ONE ·Yihao Tian, Yu Hou, Xiang Zhou, Hanhua Cheng, Rongjia Zhou	17
19	Mago, a vertebrate homolog of Drosophila Mago nashi protein, is a component of the chromatoid body in the cytoplasm of the postmeiotic spermatid 2010 ·Journal of Experimental Zoology Part B Molecular and Developmental Evolution ·Wei Zhao, Fang Zhou, Xiang Zhou, Yu Hou, Yan He, Hanhua Cheng, Rongjia Zhou	6
20	Nuclear import of human sexual regulator DMRT1 is mediated by importin-β 2007 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Ming Ying, Bo Chen, Yihao Tian, Yu Hou, Qin Li, Xuan Shang, Jinhua Sun, Hanhua Cheng, Rongjia Zhou	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Mesuraca Breakdown of academic impact, for papers by Majid Farshdousti Hagh Breakdown of academic impact, for papers by Laurens T. van der Meer Breakdown of academic impact, for papers by Yongjun Fang Breakdown of academic impact, for papers by Yuan Xia Breakdown of academic impact, for papers by Yan Jin Breakdown of academic impact, for papers by Sarmishtha De Breakdown of academic impact, for papers by Ying‐Yu Ma